Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2014. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) under the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding insider transactions rather than a financial performance report.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction where Mr. D E Troy acquired 300.305 ADSs at a price of $52.84 per ADS following the re-investment of a dividend paid on January 9, 2014.
Key Facts for Investor Verification
- Transaction Type: Increase in ADS holdings via dividend re-investment.
- Individual Involved: Mr. D E Troy (Person Discharging Managerial Responsibility).
- Quantity Acquired: 300.305 ADSs.
- Transaction Price: $52.84 per ADS.
- Dividend Date: January 9, 2014.
- Notification Date: January 16, 2014.